Edgestream Partners, L.P. Boston Scientific Corp Transaction History

Edgestream Partners, L.P.

$2.88 Billion
Q1 2025

A detailed history of Edgestream Partners, L.P. transactions in Boston Scientific Corp stock. As of the latest transaction made, Edgestream Partners, L.P. holds 2,338 shares of BSX stock, worth $232,256. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,338

Previous 23,104 89.88%

Holding current value

$232,256

Previous $2.06 Million 88.61%

% of portfolio

0.01%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$89.38 - $106.18 $1.86 Million - $2.2 Million	-20,766 Reduced 89.88%	2,338 $235,000
Q4 2024 Feb 06, 2025	BUY	$83.62 - $91.5 $1.93 Million - $2.11 Million	23,104 New	23,104 $2.06 Million
Q2 2024 Aug 09, 2024	BUY	$67.33 - $77.71 $232,625 - $268,488	3,455 Added 64.69%	8,796 $677,000
Q1 2024 May 10, 2024	BUY	$57.6 - $68.62 $307,641 - $366,499	5,341 New	5,341 $365,000
Q2 2023 Aug 10, 2023	BUY	$49.72 - $54.64 $443,999 - $487,935	8,930 New	8,930 $483,000
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $767,139 - $1.03 Million	-21,769 Reduced 44.57%	27,073 $1.01 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $874,646 - $964,463	-21,385 Reduced 30.45%	48,842 $2.16 Million
Q4 2021 Feb 15, 2022	SELL	$38.07 - $44.87 $4.22 Million - $4.97 Million	-110,764 Reduced 61.2%	70,227 $2.98 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $8.6 Million - $9.56 Million	-208,472 Reduced 53.53%	180,991 $7.85 Million
Q2 2021 Aug 10, 2021	BUY	$38.58 - $44.24 $5.81 Million - $6.67 Million	150,714 Added 63.13%	389,463 $16.7 Million
Q1 2021 May 06, 2021	BUY	$35.27 - $39.67 $102,812 - $115,638	2,915 Added 1.24%	238,749 $9.23 Million
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $7.82 Million - $9.9 Million	235,834 New	235,834 $8.48 Million
Q3 2020 Nov 10, 2020	SELL	$34.44 - $42.23 $25.9 Million - $31.8 Million	-752,567 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$30.19 - $39.11 $5.14 Million - $6.65 Million	170,091 Added 29.2%	752,567 $26.4 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $2.13 Million - $3.76 Million	-82,362 Reduced 12.39%	582,476 $19 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $10.7 Million - $12.9 Million	283,702 Added 74.44%	664,838 $30.1 Million
Q3 2019 Nov 08, 2019	BUY	$40.31 - $43.45 $4.32 Million - $4.66 Million	107,202 Added 39.13%	381,136 $15.5 Million
Q2 2019 Aug 08, 2019	BUY	$34.91 - $42.98 $1.41 Million - $1.74 Million	40,415 Added 17.31%	273,934 $11.8 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $7.69 Million - $9.52 Million	233,519 New	233,519 $8.96 Million
Q2 2018 Aug 09, 2018	SELL	$26.84 - $34.32 $507,222 - $648,579	-18,898 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $186,908 - $211,681	7,417 Added 64.6%	18,898 $516,000
Q4 2017 Feb 09, 2018	BUY	$24.79 - $29.8 $284,613 - $342,133	11,481	11,481 $285,000

Others Institutions Holding BSX

# of Institutions

1,832

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $142B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Boston Scientific Corp Transaction History